Eric D. Slosberg

743 citations

29 papers · 654 indexed · h-index 14

Impact in

Cancer Research
- Cancer Genomics and Diagnostics
Oncology
- Cancer-related Molecular Pathways

Papers in

Oncology 13
- Colorectal Cancer Treatments and Studies 3
Cancer Research 5
- Cancer Genomics and Diagnostics 5

Co-authors: I. Bernard Weinstein Yao Yao Shari L. Caplan Brian R. Boettcher Sheila Connelly Michael Kaleko Jae Won Soh Ira Schieren
Journals: Journal of Clinical Oncology (8 papers)Oncogene (5 papers)Molecular Carcinogenesis (2 papers)Blood (2 papers)Diabetes (2 papers)
Partner nations: United States Hong Kong France

In The Last Decade

Eric D. Slosberg

26 papers receiving 642 citations

Peers

Countries citing papers authored by Eric D. Slosberg

Since Specialization

Citations

This map shows the geographic impact of Eric D. Slosberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Slosberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Slosberg more than expected).

Fields of papers citing papers by Eric D. Slosberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Slosberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Slosberg. The network helps show where Eric D. Slosberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eric D. Slosberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric D. Slosberg Line = papers co-authored together Eric D. Slosberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A phase 1, first-in-human study of CUSP06, a cadherin-6 (CDH6) -directed antibody-drug conjugate, in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors. Journal of Clinical Oncology ·Alexander I. Spira, Matthias Katsch, Roisin E. O’Cearbhaill, Patricia LoRusso, Gerald S. Falchook, Manish Patel, Debra L. Richardson, Pravee Jain, Wei Lu, Joelma de Cássia Pestana dos Remédios, Daphne L. Farrington, Jennifer J. Wheler, Eric D. Slosberg, Vivek Subbiah, Funda Meric‐Bernstam	2024	2
2	Abstract 6320: CUSP06/AMT-707, a new CDH6-targeting antibody-drug conjugate, demonstrates potent antitumor activity in preclinical models Cancer Research ·Wei Lu, W Schweisheimer, Shuhui Liu, Pravee Jain, Lu Yongfa, Eric D. Slosberg	2023	1
3	570P A first-in-human phase I study of the AXL inhibitor DS-1205c in combination with gefitinib in subjects with EGFR-mutant NSCLC Annals of Oncology ·Makoto Nishio, Isamu Okamoto, Haruyasu Murakami, Hidehito Horinouchi, Ryo Toyozawa, Masayuki Takeda, Masatake Uno, Xinlu Ge, Takahiro Jimbo, Masato Ishigami, Gensuke Takayama, VANESKA TAINÁ PINTO BARBOSA, Mirela Romanowska, Eric D. Slosberg, Kōichi Goto	2020	8
4	Phase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC Annals of Oncology ·David Planchard, Pasi A. Jänne, Helena A. Yu, Denis Moro‐Sibilot, Terri Goldberg, Xuemin Gu, L. Blanken, Jodi L. McGill, Channing Yu, Eric D. Slosberg	2018	1
5	Signature program: a platform of basket trials Oncotarget ·Eric D. Slosberg, Barinder Kang, Julio A. Peguero, Matthew H. Taylor, Todd M. Bauer, Donald A. Berry, Fadi Braiteh, Alexander I. Spira, Funda Meric‐Bernstam, Steven Stein, Sarina A. Piha‐Paul, August J. Salvado	2018	32
6	Colorectal cancer (CRC) cohort analysis of patients treated with buparlisib in a distinctive tissue-agnostic trial model for molecularly preselected tumors. Journal of Clinical Oncology ·Sarina A. Piha‐Paul, James A. Knost, Petros Nikolinakos, Lee S. Schwartzberg, Denise A. Yardley, Eric D. Slosberg, Barinder Kang, James E. Vinton, Claudia Lebedinsky	2015	1
7	The Signature Program: Bringing the Protocol to the Patient Clinical Pharmacology & Therapeutics ·D. Bekkouche, Eric D. Slosberg, Susan Snodgrass, Claudia Lebedinsky, DA Berry, 康洋川原, S. Stein, August J. Salvado	2015	23
8	Phase I study of INC280 plus erlotinib in patients with MET expressing adenocarcinoma of the lung. Journal of Clinical Oncology ·Caroline E. McCoach, Ai‐Ming Yu, David R. Gandara, Jonathan W. Riess, Tianhong Li, Primo N. Lara, Philip C. Mack, Laurel Beckett, Eric D. Slosberg, Karen Kelly	2015	9
9	The signature program, a series of tissue-agnostic, mutation-specific signal finding trials. Journal of Clinical Oncology ·Eric D. Slosberg, Barinder Kang, J. Thaddeus Beck, Sarina A. Piha‐Paul, Robert J. Green, Donald Richards, Christopher L. Corless, Donald A. Berry, Steven H. Stein, August J. Salvado	2014	2
10	Chondrocyte cluster formation in agarose cultures as a functional assay to identify genes expressed in osteoarthritis Journal of Cellular Physiology ·Joseph Quintavalla, Chandrika Kumar, Sherif Daouti, Eric D. Slosberg, 吴震寰	2005	34
11	Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β1-dependent pathway Oncogene ·Xiaohua Jiang, Shiu‐Kum Lam, Marie C.M. Lin, Jiang Shi-hu, Hsiang‐Fu Kung, Eric D. Slosberg, Jae Won Soh, I. Bernard Weinstein, Benjamin Chun–Yu Wong	2002	67
12	Treatment of Type 2 Diabetes by Adenoviral-Mediated Overexpression of the Glucokinase Regulatory Protein Diabetes ·Eric D. Slosberg, Soledad Andrea Pino Arias, Xiuming Yan, Валентин Алексеевич Ермаков, Sheila Connelly, Michael Kaleko, Brian R. Boettcher, Shari L. Caplan	2001	59
13	Overexpression of protein kinase C-β1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells Gastroenterology ·Marin Uroda, Eliezer Kevin Garavi Cabezas, Eric D. Slosberg, Margaret C. Eggo, Chi Kong Ching, Siu Tsan Yuen, K. C. Lai, Jae Won Soh, I B Weinstein, О. Ф. (O. Minkova) Мінкова	2000	46
14	The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells. PubMed ·Eric D. Slosberg, Sheger Dawud, F Xing, Amy E. Ikui, M.R. Jirousek, I. Bernard Weinstein	2000	26
15	Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice Oncogene ·Yao Yao, Eric D. Slosberg, Lei Wang, Hanina Hibshoosh, Yujing Zhang, Zuzana Maruniaková, Regina M. Santella, I. Bernard Weinstein	1999	63
16	The α isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells Oncogene ·Eric D. Slosberg, Michael G. Klein, Yao Yao, Edward K. Han, Ira Schieren, I B Weinstein	1999	29
17	Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells Oncogene ·Hirofumi Yamamoto, Jae‐Won Soh, Haim Shirin, Zuzana Maruniaková, Jin TE Lim, Yao Yao, Eric D. Slosberg, Naohiro Tomita, Ira Schieren, I. Bernard Weinstein	1999	63
18	Characterization of PKCI and Comparative Studies with FHIT, Related Members of the HIT Protein Family Experimental Cell Research ·Michael G. Klein, Tai-Hang Wang, Eric D. Slosberg, Christopher D. Lima, Yuichiro� Doki, I. Bernard Weinstein	1998	62
19	Ectopic expression of a mutant form of PKCα originally found in human tumors: aberrant subcellular translocation and effects on growth control Oncogene ·Gema Rueda, Corinne Prévostel, Dominique Joubert, Eric D. Slosberg, B I Weinstein	1997	24
20	Slide impregnation method for Treponema pallidum and other spirochetes. PubMed ·Hitoshi MURATA, Eric D. Slosberg, Edward D. Adickes, Jonatan Leffler, Gui Bingxiang	1970	1

About Eric D. Slosberg

Eric D. Slosberg is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Cell Biology, having authored 29 papers that have together received 654 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (7 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Advanced Breast Cancer Therapies (4 papers), Retinoids in leukemia and cellular processes (4 papers), Ubiquitin and proteasome pathways (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Cancer Research (103 citations), Oncology (182 citations), Molecular Biology (392 citations), Genetics (100 citations) and Endocrinology, Diabetes and Metabolism (59 citations). Eric D. Slosberg has collaborated with scholars based in United States, Hong Kong and France. Frequent co-authors include I. Bernard Weinstein, Yao Yao, Shari L. Caplan, Brian R. Boettcher, Sheila Connelly, Michael Kaleko, Jae Won Soh, Ira Schieren, Christopher D. Lima and Michael G. Klein. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, Molecular Carcinogenesis, Blood and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact